CMC Specialist |
| CMC Specialist - PT/FT position located in Delaware County, Pennsylvania.
BS, preferably in C... |
|
STATISTICAL ANALYST WITH SAS NEEDED! |
| CoreTech Consulting on the of leading provider of consultants in the Pharmaceutical arena. We ... |
|
Senior Medical Writer (medical education/medical communications) |
| ApotheCom Associates, LLC
Senior Medical Writer
Medical Communications
Yardley, PA
&... |
|
STATISTICAL ANAYLST |
| Top 10 Pharmaceutical Company with a location in Collegeville, PA is seeking a Statistical Analyst ... |
|
Director of Clinical Affairs |
| Position Summary: Coordinates and executes all activities related to clinical ... |
|
Prinicipal Scientist - Virologist |
| My client, a leading contract pharmaceutical services provider to customers worldwide, has an ... |
|
Scientific eLNB Deployment Assistant |
| Scientific eLNB Deployment Assistant
BODY{ FONT-FAMILY: Arial; FONT-SIZE: ... |
|
SAS Programmer |
| Apex Systems Inc is currently seeking 4 experienced SAS Programmers with experience with the ... |
|
QA Quality Assurance Specialist Bucks County Area PA / NJ |
| QA Specialist Bucks County, PA
Description:Assist in maintaining regulatory compliance subject to GC... |
|
Senior Validation Associate |
| Senior Validation Associate
Octagon Research Solutions, Inc., is a fast growing D... |
|
|
VP Clinical Research and Development
| Details |
Country: USA
Location: PA Radnor
Total applied: 11
Relevant Work Experience: 5+ to 7 Years
Career Level: Executive (SVP, VP, Department Head, etc)
Education Level: Doctorate
Job Type: Employee
Job Status: Full Time
|
|
VP Clinical Research and Development
PolyMedix
VP of Clinical Research and Development
PolyMedix has just received $23 million in financing and is currently located at the Science Center in Philadelphia,
PolyMedix is developing entirely novel computational and synthetic chemistry approaches that should be broadly applicable to developing novel small molecule and oligomer therapeutic drugs for membrane targets and protein:protein interactions. The compounds and methods of design are de novo and proprietary, and provide a novel platform for the design of inhibitors that have been difficult to develop using traditional small molecule approaches. PolyMedix's protein computational technologies were developed by Drs. William DeGrado, Michael Klein, and Jeffery Saven at the University of Pennsylvania. This work is of potentially monumental importance, with vast commercial opportunities.
The unifying element underlying all of PolyMedix's computational platform is the ability to build compounds to fill protein spatial coordinates: These compounds can be designed based on either pair of a ligand:receptor or protein:protein interaction pair. This computational technology platform as used to develop its first program: a line of unique anti-infective drugs for which bacterial resistance has so far proven highly unlikely to develop
Shortly, we will be relocating to a new facility in Radnor, PA as soon as the new labs are completed. PolyMedix is currently looking to add to its team:
VP of Clinical Research and Development
VP/Director Drug Development
Director Chemistry
Director Biology
Director Toxicology
Director Microbiology
Analytical Chemists
Organic/Medicinal Chemists
Biochemists
Chief Medical Officer
Please e-mail your resume to: rmainc1@comcast.net
Please see our website at: http://www.polymedix.com
VP of Clinical Research and Development
VP of Clinical Research will be responsible for the full scope of Clinical and Medical Affairs functions, including clinical trials, clinical research, data collection, safety and medical information programs. This individual will be responsible for working closely with Research & Development to ensure an effective linkage to Phase I, II and III clinical trial design, strategy, and ultimately to NDA filing. He/she will provide leadership to the whole organization in moving compounds effectively into, and through, the clinic. We are looking for a dynamic high energy executive.
RESPONSIBILITIES:
The VP of Clinical Research is responsible for ensuring effective design of experimental protocols, reviewing promotional materials for scientific accuracy, serving as the clinical lead for advisory meetings, and advising all levels of executive management in development and implementation of clinical strategy.
The VP of Clinical Research will provide leadership in establishing the studies essential for determining the safety, efficacy, and marketability of drug candidates. He/she will also serve as the principal medical monitor responsible for overseeing contract research organization (CRO) activities, the implementation of clinical trials, and for the interpretation of the results from investigations. The VP of Clinical Research serves as a key member of the executive team responsible for identifying/implementing the actions necessary to achieve corporate goals.
SPECIFIC DUTIES
? Designs clinical trial protocols and selects Clinical Investigators and Clinical Research Organizations
? Writes clinical sections of all regulatory documents, including the Investigational New Drug Application and Applications for marketing approval
? Evaluates safety data from clinical trials and reports safety findings to regulatory authorities and licensing partners
? Writes clinical study reports according to regulatory (FDA/ICH) guidelines
? Reports status of clinical programs to Project Teams and Management
? Supports Business Development licensing activities including the evaluation of the competitive landscape
? Identifies and maintains liaison with leading investigators in the areas of medicine where products are being developed
? Reports clinical study findings at professional meetings
? Manages clinical trial budget for both CROs and study sites
? Promotes continuing education and development of personnel system
? Assists project teams to identify clinical indications appropriate for the investigational drugs
? Assists research teams with the identification of new therapeutic areas of focus for potential drug candidates
ADDITIONAL REQUIREMENTS:
? MD or MD/PhD degree with specialty/certification in internal medicine and subspecialty experience preferably in anti infectious drugs
? Minimum 5+ years experience in a pharmaceutical or biopharmaceutical company, preferably in a fast-paced, dynamic environment.
? Demonstrated expertise in managing complex collaborations and teams in support of executing clinical trials effectively, including effective management of projects and timelines and interpretation/evaluation of clinical data.
? Must be knowledgeable with FDA requirements, good clinical practices, and pharmaceutical clinical development.
? Demonstrated leadership experience, including excellent analytical, planning and communication skills in a dynamic environment.
? Excellent oral, written, and interpersonal communication skills.
?
|
| Related jobs |
|
|
Medical Education Research Liaison - GI/Urology - Northeast Region
Catch the Spirit... There's a spirit that permeates our company. And that spirit comes from our people. We're creative, energetic, and entrepreneurial. Founded by the ...
|
|
|
VALIDATION ENGINEERS, SPECIALISTS, & PROJECT MANAGERS
VALIDATION ENGINEERS, SPECIALISTS, & PROJECT MANAGERS
Compli, LLC is Regulatory Compliance, and Validation Contract Services Provider dedicated to ...
|
|
|
Product Director
Description: Reporting to the Vice President, of Marketing, the Product Director will be responsible for planning, developing, and executing strategic plans for MYO...
|
|
|
EPIDEMIOLOGIST
Top 10 Pharmaceutical Company with a location in Collegeville PA is seeking a Consulting Epidemiologist to join their team.
?
Requirements:
At least 2 years of ...
|
|
|
SAS Programmer / Developer
We are in need of a SAS Programmer for one of the world leaders in the research and development of innovative, high-quality health care products. Candidate will migrate ...
|
|
|
Senior SAS Programmer
Top 10 Pharmaceutical Company with a location in Collegeville PA is seeking 2 Sr. SAS programmers to join their team. Compensation is commensurate upon experience.
&...
|
|
|
Process Engineer
Our client, a leader in its industry, a leading worldwide manufacturer of fine chemicals, drug substances and specialty compounds used in the pharmaceutical industry, ...
|
|
|
Research Technician
Sanofi-Synthelabo and Aventis Pharmaceuticals, part of the sanofi-aventis Group are facing the future and leading the way as the 3rd largest pharmaceutical company in ...
|
|
|
Study Initiation Coordinator
Our client, a well established pharmaceutical organization, is currently in need of a qualified,
STUDY INITIATION COORDINATOR
SUMMARY:
Assists the ...
|
|
|
Senior Director, Trial Design and Management, Clinical Pharmacology and Experimental Medicine
To learn more about opportunities with the Johnson & Johnson Family of Companies, visit us ...
|
|
| Related press releases |
Small cut - deeper wounds?
After 14 months of standing pat, the first move was always going to surprise somebody. But last week's quarter per cent cut in base rates by the Bank of England was a rud...
|
|
Dental caries in the Bank gift horse's mouth
At 11.59 yesterday morning, the City was thinking about an early lunch. The Bank of England was about to announce its decision on interest rates, but few expected anythin...
|
|
Keep your sights fixed on safe returns in retirement
The fact that the Bank of England base rate has remained unchanged at 4 per cent for more than a year ought to be good news for savers - particularly those who rely on in...
|
|
Big bad apple
In Arthur Penn's vastly underrated but nonetheless awful 1976 movie The Missouri Breaks, Marlon Brando so completely dominates the action with his ridiculous Irish brogue...
|
|
Penny drops on crafty cut
Several leading banks were this week accused of using the festive period to bury bad news about cuts to their savings rates. The Halifax, Bank of Scotland, First Direct a...
|
|
Loss and retention
The massive differences in drop-out rates between universities are a running sore in the higher education sector. For years universities and colleges resisted informed de...
|
|
ECB's slow progress towards 2%
Nobody could ever accuse the ECB of being hasty. Wim Duisenberg's announcement yesterday of a half-point cut in interest rates to 2.75% was the first move in 13 months - ...
|
|
Size of cut shocks Wall Street
The Federal Reserve, America's central bank, shocked Wall Street last night when it unveiled an emergency half-point cut in US interest rates to prevent the world's large...
|
|
Stone cold certainties will force the Fed's hand
It is no longer a question of whether Alan Greenspan will cut American interest rates, but when and by how much. There were already signs from the weekend's deep-throat s...
|
|
What the tourist board doesn't tell you
People travelling to South Africa are paying much higher rates for food and accommodation simply for having a British accent. Hotels and restaurants are charging up to fo...
|
|
|
|